Canggang Railway LimitedHKEX: 2169

Interim Report 2026

Sep 28, 2026 at 1:50 PM UTC · Issued by Canggang Railway Limited via HKEXnews

HKEX: 2169

View Attachment

View original source (HKEXnews)

Earlier from Canggang Railway

Nuance Pharma Announces Acceptance for Review of the New Drug Application for Ohtuvayre® (ensifentrine) by the National Medical Products Administration of China for the maintenance treatment of chronic obstructive pulmonary diseaseJan 27

All Canggang Railway news releases